This study demonstrates that p53 potentially contributes to downregulating the oncogenic lncRNA PVT1, thereby suppressing the activation of TGF-β and TGF-β mediated GBM progression by modulating the lncRNA PVT1-TGF-β axis [94]. The gene discussed is TP53; the disease is glioblastoma.